EssilorLuxottica Societe Anonyme Revenue 2011-2018 | ESLOY

EssilorLuxottica Societe Anonyme annual/quarterly revenue history and growth rate from 2011 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • EssilorLuxottica Societe Anonyme revenue for the quarter ending December 31, 2018 was $M, a NAN% increase year-over-year.
  • EssilorLuxottica Societe Anonyme revenue for the twelve months ending December 31, 2018 was $0M, a NAN% increase year-over-year.
  • EssilorLuxottica Societe Anonyme annual revenue for 2018 was $12.754B, a 50.65% increase from 2017.
  • EssilorLuxottica Societe Anonyme annual revenue for 2017 was $8.466B, a 7.53% increase from 2016.
  • EssilorLuxottica Societe Anonyme annual revenue for 2016 was $7.873B, a 5.57% increase from 2015.
EssilorLuxottica Societe Anonyme Annual Revenue
(Millions of US $)
2018 $12,754
2017 $8,466
2016 $7,873
2015 $7,458
2014 $7,537
2013 $6,728
2012 $6,416
2011 $5,835
2010 $5,168
EssilorLuxottica Societe Anonyme Quarterly Revenue
(Millions of US $)
Q4 2018
Q2 2018
Q4 2017
Q2 2017
Q4 2016
Q4 2015
Q2 2015
Q4 2014
Q2 2014
Q4 2013
Q2 2013
Q4 2012
Q2 2012
Q4 2011
Q2 2011
Q4 2010
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $32.865B $12.754B
EssilorLuxottica Soci?t? is involved in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. The company's brand portfolio consists of Ray-Ban, Oakley, Varilux(R), Transitions(R), Sunglass Hut and LensCrafters. EssilorLuxottica Soci?t?, formerly known as Essilor International Soci?t? Anonyme, is based in Paris, France.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $146.323B 26.71
Medtronic (MDT) Ireland $145.061B 20.36
Stryker (SYK) United States $80.552B 27.85
Boston Scientific (BSX) United States $53.588B 25.99
Baxter (BAX) United States $44.924B 27.24
Zimmer Biomet Holdings (ZBH) United States $28.253B 18.08
Coloplast (CLPBY) Denmark $25.488B 40.69
Lonza Group Ag (LZAGY) Switzerland $25.356B 0.00
Terumo (TRUMY) Japan $24.335B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $20.897B 0.00
ResMed (RMD) United States $18.864B 35.95
Sunny Optical Technology (SNPTF) China $16.014B 0.00
Bio-Rad Laboratories (BIO) United States $10.229B 54.83
Insulet (PODD) United States $9.266B 549.07
Perrigo (PRGO) Ireland $7.333B 13.51
Canopy Growth (CGC) Canada $7.030B 0.00
Hill-Rom Holdings (HRC) United States $6.817B 20.33
Haemonetics (HAE) United States $6.460B 48.76
William Demant Holdings (WILYY) Denmark $5.988B 0.00
GN STORE NORD (GNNDY) Denmark $5.344B 27.61
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
Aurora Cannabis (ACB) Canada $3.786B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.648B 0.00
NuVasive (NUVA) United States $3.463B 27.61
Neogen (NEOG) United States $3.393B 56.77
ICU Medical (ICUI) United States $3.219B 20.88
Quidel (QDEL) United States $2.561B 25.43
Hutchison China MediTech (HCM) Hong Kong, SAR China $2.550B 0.00
Agios Pharmaceuticals (AGIO) United States $1.943B 0.00
National Vision Holdings (EYE) United States $1.805B 38.97
Cardiovascular Systems (CSII) United States $1.730B 0.00
Aphria (APHA) $1.197B 0.00
VAREX IMAGING (VREX) United States $1.103B 25.42
AtriCure (ATRC) United States $1.057B 0.00
Phibro Animal Health (PAHC) United States $0.853B 13.88
Eagle Pharmaceuticals (EGRX) United States $0.843B 21.50
Omeros (OMER) United States $0.782B 0.00
NanoString Technologies (NSTG) United States $0.760B 0.00
Lantheus Holdings (LNTH) United States $0.732B 19.25
LeMaitre Vascular (LMAT) United States $0.696B 41.24
PetIQ (PETQ) United States $0.676B 15.98
Cerus (CERS) United States $0.627B 0.00
Surmodics (SRDX) United States $0.605B 114.95
MacroGenics (MGNX) United States $0.538B 0.00
Quanterix (QTRX) United States $0.527B 0.00
OraSure Technologies (OSUR) United States $0.523B 24.21
TG Therapeutics (TGTX) United States $0.518B 0.00
Owens & Minor (OMI) United States $0.450B 13.47
Meridian Bioscience (VIVO) United States $0.428B 13.37
Utah Medical Products (UTMD) United States $0.356B 26.11
Zynex (ZYXI) United States $0.340B 36.14
BioLife Solutions (BLFS) United States $0.332B 102.06
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.326B 0.00
United Health Products (UEEC) United States $0.242B 0.00
Bovie Medical (APYX) United States $0.229B 0.00
Vapotherm (VAPO) United States $0.180B 0.00
Repro-Med Systems (REPR) United States $0.163B 0.00
Rockwell Medical (RMTI) United States $0.158B 0.00
Cytosorbents (CTSO) United States $0.146B 0.00
Female Health (VERU) United States $0.140B 0.00
Fonar (FONR) United States $0.130B 9.14
Liberty Health Sciences (LHSIF) Canada $0.106B 0.00
Chembio Diagnostics (CEMI) United States $0.094B 0.00
Chimerix (CMRX) United States $0.089B 0.00
United-Guardian (UG) United States $0.085B 20.00
Nephros (NEPH) United States $0.083B 0.00
MTech Acquisition (KERN) United States $0.062B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.053B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Surface Oncology (SURF) United States $0.037B 0.00
Senestech (SNES) United States $0.024B 0.00
Trinity Biotech (TRIB) Ireland $0.019B 0.00
GUARDION HEALTH (GHSI) United States $0.018B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.012B 0.00
Capricor Therapeutics (CAPR) United States $0.010B 0.00
Valeritas Holdings (VLRX) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.005B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00